The Orphan Drugs Market development is reshaping the landscape of pharmaceutical innovation and rare disease care. As traditional drug development models face limitations in addressing ultra-rare conditions, orphan drug frameworks offer a revolutionary alternative. The market, valued at USD 263.10 billion in 2026, is expected to witness steady growth through 2035. Factors such as the rising...